Non-invasive prenatal testing kit for detection of trisomy 21, 18, and 13 using reversible termination sequencing technology. Provides chromosomal abnormality screening during pregnancy.
Manufactured by
Luoyang Geneture Medical Technology Co.,Ltd.
China
Luoyang Geneture Medical Technology CO., LTD. rely on independent core technologies, Geneture has built three technology platforms of automated nucleic acid extraction, qPCR and high-throughput sequencing, providing one-stop solutions for individualized tumor detection and genetic disease screening, enabling healthcare providers and patients with accurate, timely, and cost-effective diagnostic services.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Salus BioMed Co., Ltd.
China · 2 relevant products
LifeOS Genomics Corporation
Taiwan · 2 relevant products
Origin Biotechnology Co., Ltd.
Taiwan · 8 relevant products
77 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →18 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 115 closest product alternatives
Shenzhen Salus BioMed Co., Ltd. · China
NIPT is a prenatal screening method that uses high-throughput gene sequencing and molecular genetic techniques to detect fetal cell-free DNA fragments in maternal peripheral blood, assessing the risk of common fetal chromosomal aneuploidies (T21, T18, T13). The test extracts free DNA from maternal blood containing fetal genetic information and analyzes it through high-throughput sequencing to detect abnormalities in fetal chromosome number and structure. Compared to traditional maternal serum screening, NIPT offers advantages of high detection rate and low false positive rate, while avoiding the risks associated with invasive methods such as amniocentesis.
LifeOS Genomics Corporation · Taiwan
A closed system, ready-to-use, clinically validated PCR-based assay panel for assessing chromosomal aneuploidy including T21, T18, T13, and sex chromosomes X and Y. It is specifically tailored for non-invasive prenatal testing applications.
Origin Biotechnology Co., Ltd. · Taiwan
A prenatal diagnostic test for the detection of chromosomal number abnormalities in the fetus.
112 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products